Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada.

about

Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada.

Item

http://www.wikidata.org/entity/Q54998885

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Incidence of symptomatic venou ...... registry in Montreal, Canada.

@en

Incidence of symptomatic venou ...... registry in Montreal, Canada.

@nl

type

Item

label

Incidence of symptomatic venou ...... registry in Montreal, Canada.

@en

Incidence of symptomatic venou ...... registry in Montreal, Canada.

@nl

prefLabel

Incidence of symptomatic venou ...... registry in Montreal, Canada.

@en

Incidence of symptomatic venou ...... registry in Montreal, Canada.

@nl

P1476

Incidence of symptomatic venou ...... registry in Montreal, Canada.

@en

P2093

Andreea Banica

http://www.w3.org/2001/XMLSchema#string

Andréa Senay

http://www.w3.org/2001/XMLSchema#string

Benoit Benoit

http://www.w3.org/2001/XMLSchema#string

G Yves Laflamme

http://www.w3.org/2001/XMLSchema#string

Hai Nguyen

http://www.w3.org/2001/XMLSchema#string

Josée Delisle

http://www.w3.org/2001/XMLSchema#string

Julio C Fernandes

http://www.w3.org/2001/XMLSchema#string

Michel Malo

http://www.w3.org/2001/XMLSchema#string

Milanne Trottier

http://www.w3.org/2001/XMLSchema#string

Pierre Ranger

http://www.w3.org/2001/XMLSchema#string

P2860

Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

The impact of national guidelines for the prophylaxis of venous thromboembolism on the complications of arthroplasty of the lower limb.

Risk factors and distribution of symptomatic venous thromboembolism in total hip and knee replacements: prospective study.

Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.

Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review.

Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry.

Current and emerging strategies in the management of venous thromboembolism: benefit-risk assessment of dabigatran.

P304

81-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/VHRM.S150474

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29780248

http://www.w3.org/2001/XMLSchema#string

P921

venous thromboembolism

P932

5951148

http://www.w3.org/2001/XMLSchema#string